Discuss the ethical and regulatory challenges posed by technologies that can directly modulate brain activity.

Technologies that can directly modulate brain activity, such as optogenetics, use light to switch chosen neurons on or off. This lets researchers change memory, emotion and behaviour. Optogenetics won the 2026 Nobel Prize in Physiology or Medicine for "light-gated ion channels and optogenetics" [1]. The power to alter the mind raises ethical and regulatory challenges that the law has not yet caught up with.

Ethical Challenges

• Consent and autonomy: people with psychiatric illness may lack the capacity to decide. Changing mood circuits also blurs the line between treating a person and altering their personality.
• Irreversible genetic change: optogenetics needs a virus (AAV) to put genes into cells, plus a light source [2]. These changes are hard to undo.
• Hype versus evidence: the best human result so far is partial vision in one blind patient wearing goggles [2]. Later trials are encouraging [3], but claims of a "cure" can exploit desperate patients.
• Mental privacy and manipulation: neural data can reveal thoughts and emotions. UNESCO warns it could be misused for surveillance, targeted marketing and political influence [4].
• Equity and enhancement: costly therapies may widen health gaps. Using them to enhance healthy people raises questions of fairness [4].

Regulatory Challenges

• Legal vacuum: India has no law specific to neurotechnology. The UNESCO Recommendation on the Ethics of Neurotechnology (2025) is not binding [4].
• Fragmented oversight: one therapy combines a gene, a virus and a device [2]. It therefore falls across separate approval routes for drugs, devices and gene therapy.
• Outdated law: the Mental Healthcare Act, 2017 gives rights-based safeguards such as advance directives and limits on ECT [5]. It was written before gene-based brain modulation existed.
• Capacity: the National Brain Research Centre, Manesar (DBT) [6], gives India a base for neuroscience research. Skills in ethics review and regulation must grow at the same pace as the research.

Brain-modulating tools are very valuable for research but carry risks to autonomy, privacy and safety. India should move step by step. It can start with therapies for the eye, protect neural data and set consent rules in line with UNESCO's principle of the "inviolability of the human mind" [4]. This would let the science advance while upholding the dignity guaranteed by Article 21 and SDG 3.